Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer
出版年份 2021 全文链接
标题
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer
作者
关键词
-
出版物
Frontiers in Genetics
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-06-15
DOI
10.3389/fgene.2021.662734
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105
- (2020) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Physical activity, health‐related quality of life, and adjuvant endocrine therapy–related symptoms in women with hormone receptor–positive breast cancer
- (2020) Vanessa B. Sheppard et al. CANCER
- Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
- (2018) Lynne I. Wagner et al. BREAST CANCER RESEARCH AND TREATMENT
- Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
- (2018) W. Wulaningsih et al. BREAST CANCER RESEARCH AND TREATMENT
- Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study
- (2018) N. Nabieva et al. EUROPEAN JOURNAL OF CANCER
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- (2018) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer
- (2018) Jacqueline M. Dempsey et al. PHYSIOLOGICAL GENOMICS
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Higher symptom burden is associated with lower function in women taking adjuvant endocrine therapy for breast cancer
- (2018) Andrea Sitlinger et al. Journal of Geriatric Oncology
- Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment
- (2017) Ethan Basch et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer
- (2017) Roxanne E. Jensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients
- (2017) Daniel L Hertz et al. PHARMACOGENOMICS
- Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL)
- (2016) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Responsiveness of 8 Patient-Reported Outcomes Measurement Information System (PROMIS) measures in a large, community-based cancer study cohort
- (2016) Roxanne E. Jensen et al. CANCER
- Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients
- (2016) A. Lintermans et al. EUROPEAN JOURNAL OF CANCER
- Clinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples
- (2016) Benjamin D. Schalet et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer
- (2016) Kunal C. Kadakia et al. ONCOLOGIST
- CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1–98 trial
- (2015) Brian Leyland-Jones et al. BREAST CANCER RESEARCH AND TREATMENT
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients
- (2015) Jingxuan Wang et al. PLoS One
- Adjuvant Aromatase Inhibitor Therapy in Early Breast Cancer: What Factors Lead Patients to Discontinue Treatment?
- (2015) Luca Moscetti et al. TUMORI
- Improving an electronic system for measuring PROs in routine oncology practice
- (2015) Albert W. Wu et al. Journal of Cancer Survivorship
- Adjuvant Aromatase Inhibitor Therapy in Early Breast Cancer: What Factors Lead Patients to Discontinue Treatment?
- (2015) Luca Moscetti et al. TUMORI JOURNAL
- Germline variants in the CYP19A1 gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial
- (2014) Duveken B. Y. Fontein et al. BREAST CANCER RESEARCH AND TREATMENT
- Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy
- (2014) Kelley M. Kidwell et al. CANCER
- Musculoskeletal pain and health-related quality of life among breast cancer patients treated with aromatase inhibitors
- (2014) Temitope Olufade et al. SUPPORTIVE CARE IN CANCER
- Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer
- (2014) Sayaka Kuba et al. Breast Cancer
- Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?
- (2014) Anna Kemp et al. SpringerPlus
- COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy
- (2013) P. Hadji et al. ANNALS OF ONCOLOGY
- Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study
- (2013) Natalia Garcia-Giralt et al. BREAST CANCER RESEARCH AND TREATMENT
- Persistence in patients with breast cancer treated with tamoxifen or aromatase inhibitors: a retrospective database analysis
- (2013) P. Hadji et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer
- (2013) N. Lynn Henry et al. BREAST CANCER RESEARCH AND TREATMENT
- Indications of Clinical and Genetic Predictors for Aromatase Inhibitors Related Musculoskeletal Adverse Events in Chinese Han Women with Breast Cancer
- (2013) Jingxuan Wang et al. PLoS One
- Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
- (2012) Caitlin C. Murphy et al. BREAST CANCER RESEARCH AND TREATMENT
- Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer
- (2012) N. Lynn Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- Feasibility and value of PatientViewpoint: a web system for patient-reported outcomes assessment in clinical practice
- (2012) Claire F. Snyder et al. PSYCHO-ONCOLOGY
- Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer
- (2011) In Hae Park et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients
- (2011) Kathleen J. Yost et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
- (2010) Dawn L. Hershman et al. BREAST CANCER RESEARCH AND TREATMENT
- Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors
- (2010) James N. Ingle et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
- (2010) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors
- (2009) Jun J. Mao et al. CANCER
- PatientViewpoint: a website for patient-reported outcomes assessment
- (2009) Claire F. Snyder et al. QUALITY OF LIFE RESEARCH
- Distributions of Hardy–Weinberg Equilibrium Test Statistics
- (2008) R. V. Rohlfs et al. GENETICS
- Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer
- (2008) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search